Psychologic treatment for hypertension can be efficacious

Preventive Cardiology

Volumn 6, Issue 1, 2003, Pages 48-53

  Linden, Wolfgang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MONITORING; CLINICAL PROTOCOL; EXERCISE; HUMAN; HYPERTENSION; PSYCHOTHERAPY; REVIEW; SOCIAL PSYCHOLOGY; SODIUM RESTRICTION; WEIGHT REDUCTION;

EID: 0037413148     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2003.0962.x     Document Type: Review

References (32)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pessure. Arch Intern Med. 1997;157(21):2413-2446.
2. Tomiak M, Gentleman JF. Risk factors for hypertension as measured by the Canada Health Survey. Health Rep. 1993;5:419-430.
3. Furberg CD, Cutler JA. Diuretic agents versus beta-blockers: comparison of effects on mortality, stroke and coronary events. Hypertension. 1989;13(suppl I):I57-I61.
4. Kaplan, NM. Clinical Hypertension. Baltimore, MD: Williams & Wilkins; 1990.
5. Kawachi I, Malcolm, LA. The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal. J Hypertens. 1991;9(3):199-208.
6. Thuermer HL, Lund-Larsen PG, Tverdal A. Is blood pressure treatment as effective in a population setting as in controlled trials? Results from a prospective study. J Hypertens. 1994;12:481-490.
7. Chockalingam A, Abbott D, Bass M, et al. Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia. CMAJ. 1990,142(12):1397-1409.
8. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148(5):1023-1038.
9. Linden W. Biopsychological barriers to the behavioral treatment of essential hypertension. In: Linden W, ed. Biological Barriers in Behavioral Medicine. New York, NY: Plenum Publishing Corp.; 1988.
10. Gerin W, Pickering TG, Glynn L, et al. A historical context for behavioral models of hypertension. J Psychosom Res. 2000;48:369-378.
11. Spence JD, Barnett PA, Linden W, et al. Recommendations on stress management. CMAJ. 1999;160:S46-S50.
12. Andrews G, McMahon SW, Austin A, et al. Hypertension: comparison of drug and non-drug treatments. BMJ. 1984;284:1523-1526.
13. Ward MM, Swan GE, Chesney MA. Arousal reduction treatments for mild hypertension: a meta-analysis of recent studies. In Julius S, Bassett DR, eds. Behavioral Factors in Hypertension. North Holland: Elsevier Publishers; 1987:285-302.
14. Linden W, Chambers LA. Clinical effectiveness of non-drug therapies for hypertension: a meta-analysis. Ann Behav Med. 1994;16:35-45.
15. Jacob RG, Chesney MA, Williams DM, et al. Relaxation therapy for hypertension: design effects and treatment effects. Ann Behav Med. 1991;13:5-17.
16. Johnston DW, Gold A, Kentish J, et al. Effect of stress management on blood pressure in mild primary hypertension. BMJ. 1993;306:963-966.
17. National High Blood Pressure Education Program Working Group. Report on Ambulatory Blood Pressure Monitoring. Washington, DC: National Institutes of Health; 1990. NIH Publication No. 90-3028.
18. Siegel WC, Blumenthal JA, Divine GW. Physiological, psychological, and behavioral factors and white coat hypertension. Hypertension. 1990;16:140-146.
19. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA. 1988;259:225-228.
20. Perloff D, Sokolow M, Cowan R, et al. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens. 1989;7:S3-S10.
21. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249:2792-2798.
22. Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:93-98.
23. Mancia G, Ferrari A, Gregorini L, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983;53:96-104.
24. Ohkubo T, Imai Y, Tsuji I, et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion - the Ohasama study. Hypertension. 1998;32:255-259.
25. Kaufmann PG, Jacob RG, Ewart CK, et al., for the HIPP Investigators. Hypertension Intervention Pooling Project. Health Psychol. 1988;7(suppl):209-224.
26. Clifford PA, Tan SY, Gorsuch RL. Efficacy of a self-directed behavioral health change program: weight, body composition, cardiovascular fitness, blood pressure, health risk, and psychosocial mediating variables. J Behav Med. 1991;14:303-323.
27. Kostis JB, Rosen RC, Brondolo E, et al. Superiority of non-pharmacologic therapy compared to propranolol and placebo in men with mild hypertension: a randomized, prospective trial. Am Heart J. 1992;123:466-474.
28. Linden W, Lenz JW, Con AH. Individualized stress management for primary hypertension: a controlled trial. Arch Intern Med. 2001;161:1071-1080.
29. Davidson K, MacGregor MW, Stuhr J, et al. Constructive anger verbal behavior decreases resting blood pressure: a secondary analysis of a randomized controlled hostility intervention. Int J Behav Med. 1999;6:268-278.
30. Rutledge T, Hogan BE. Time will tell: a quantitative review of prospective evidence linking psychological factors with hypertension development. Psychosom Med. 2002;64:758-766.
31. Jorgensen RS, Johnson BT, Kolodziej ME, et al. Elevated blood pressure and personality: a meta-analytic review. Psychol Bull. 1996;120:293-320.
32. McGrady A, Linden W. Hypertension. In: Schwartz MS, ed. Biofeedback: A Practitioner's Handbook. New York, NY: Guilford Press. In Press.